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Abstract 
Background and aim: Coexisting cardiovascular disease in pregnancy is associated with high maternal morbidity and 
mortality. These patients pose a great challenge to both anesthesiologist and obstetrician. Present study was aimed at 
reviewing the perioperative management and outcome of obstetrical surgeries in women who had coexisting 
cardiovascular disease in a tertiary care teaching institute.  
Materials and Methods: Departmental database of all pregnant patients with coexisting cardiovascular diseases who 
underwent obstetrical surgeries during January 2011 to August 2016 were reviewed. Patients functional status, 
obstetrical history, stage of labor, type of anaesthesia, monitoring, hemodynamics, post operative care and baby outcome 
were noted. Data are expressed in absolute number and percentage scale and INSTAT software was used for measuring 
central tendencies and dispersion. 
Results: A total of 22 women (mean ± Standard deviation: SD age 26.18 ± 4.78 years) were found eligible and included 
for analysis. 21(95.45%) patients underwent cesarean section and one medical termination of pregnancy. 68.18% cases 
were done under subarachnoid block. Most of the patient needed post operative high dependant unit care, one patient 
developed mild pulmonary edema and no maternal and fetal deaths were noted. All the babies were born with APGAR > 
7 at 1 min. No patient was managed using pulmonary artery catheter or continuous cardiac output monitoring. 
Conclusion: Pregnant patients with coexisting cardiovascular disease need multidisciplinary approach, timely delivery 
and intensive therapy in perioperative period. They can be safely delivered under subarachnoid blocks. Pulmonary artery 
catheterization is probably not an essential for hemodynamics management of such patients in perioperative 
management. 
Keywords: Pregnancy, cardiovascular disease, anaesthesia, hemodynamic monitoring, cesarean section.  . 
1. Introduction 
Cardiovascular disease is one of the leading and 
the most common indirect cause of pregnancy related 
maternal deaths in the developed countries. It contributes 
to 10 – 13% of the maternal deaths and the contribution as 
cause is in increasing trend.[1,2] A dynamic process like 
pregnancy leads to many significant physiological changes 
in cardiovascular system including notable changes in 
hemodynamics.[3] Co-existing cardiovascular diseases in 
pregnant women leads to worsening situation. 
Management of such expectant mothers in peripartum 
period is a great challenge for both obstetrician and 
anesthesiologists. Hemodynamic management remains one 
of the primary concerns along with safe delivery of baby 
and well being of mother. Large prospective studies 
comparing the outcome of baby and mother with different 
modalities of hemodynamic monitoring and anesthetic 
techniques are relatively missing. Therefore, gold standard 
or strong evidence based recommendations in this aspect is 
also lacking.  
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The current study was aimed at reviewing the 
perioperative management of pregnant women with 
cardiovascular coexisting diseases who underwent 
obstetrical surgery. This will help perioperative care givers 
to formulate a better management plan. It will also 
contribute to the data bank for making evidence based 
decisions in future.  
 
2. Materials and Methods 
After approval from the Institute authority, 
departmental database of all pregnant patients with 
coexisting cardiovascular diseases who underwent 
obstetrical surgeries during January 2011 to August 2016 
were reviewed. Age, obstetrical history, functional status, 
urgency of cesarean delivery, [4] type of anaesthesia, 
monitoring, hemodynamics, post operative care and baby 
outcome in terms of APGAR below 7 at one minute and 
neonatal intensive care (NICU) treatment requirements 
were noted. Use of vasopressor and high dependant units 
(HDU) or intensive care units (ICU) for postoperative care 
were also noted. A master chart in Microsoft Excel 2007 
(Microsoft Corporation, USA) was prepared for these data. 
Quantitative data are expressed in absolute number and 
percentage scale. Metric data were further analyzed for 
measuring central tendencies and dispersions using 
INSTAT software (GraphPad Prism Software, La Zolla, 
CA, USA). The cohort was further sub grouped based on 
anesthetic management and major events were compared 
using Fishers exact test and p < 0.05 was considered as 
significant.  
 
3. Results 
A total of 22 pregnant women underwent 
obstetrical surgeries during the study period and were 
included for analysis. The mean ± standard deviation: SD 
(95% confidence interval: CI) age 26.18 ± 4.78 (24.05 – 
28.30) years. 21 (95.45%) of the obstetrical surgery was 
lower segment cesarean section (LSCS) and one was 
medical termination of pregnancy. The gravida, parity and 
gestational ages of the pregnant women are described in 
table 1. The surgeries performed, urgency grade of Lucas 
for the LSCS, [4] and New York Heart Association 
(NYHA) classes for the patients having cardiac diseases 
are also shown in table 1.  
 
Table 1: Demographic, obstetrical and functional status distributions of the cohort 
 
 Mean ± SD / n (%) 95%  CI 
Age (years) [N=22] 26.18 ± 4.78 24.05 – 28.30 
Emergency LSCS 
Routine LSCS 
MTP 
19 (86.36) 
2 (9.09) 
1 (4.55) 
 
Gravida [N=22]  
Primigravida  
Multigravida  
1.72 ± 1.20 
13 (59.09) 
09 (40.91) 
1.19 – 2.26 
Parity [N=22]  
Nulliparous 
Primiparous  
Multiparous  
0.45 ± 0.73 
15 (68.18) 
04 (18.18) 
03 (13.64) 
0.127 – 0.78 
Gestational age for all (weeks) 
Gestational age for LSCS (weeks) 
36.68 ± 6.60 
38. 0 ± 2.38 
33.75 – 39.61 
36.91 – 39.08 
Urgency grade of Lucas 
1 
2 
3 
4 
2.42 ± 0.87 
3 (14.28) 
8 (38.10) 
8 (38.10) 
2 (9.52) 
2.03 – 2.82 
NYHA for cardiac patients [N=18] 
I 
II 
III 
IV 
2.05 ± 0.93 
6 (33.33) 
6 (33.33) 
5 (27.78) 
1 (5.56) 
1.58 – 2.52 
ASA status [N=22] 
1 
2 
3 
4 
5 
2.72 ± 0.82 
0 
11 (50) 
6 (27.27) 
5 (22.73) 
0 
2.36 – 3.09 
(SD- standard deviation, CI – confidence interval, LSCS – lower segment cesarean section, MTP- medical termination of pregnancy, 
NYHA – New York Heart Association, ASA – American Society of Anesthesiologists, N – total number, n - number) 
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Nineteen out of the 22 pregnant women were 
having co-existing cardiac disease while rest 3 (13.63%) 
were having vascular disease and rheumatic fever. 16 
(76.19%) out of 21 LSCS patients were having one or 
more obstetrical comorbidities. The cardiovascular and 
obstetrical comorbidities are mentioned in Table 2. Only 
16 patients’ data with regard to pulmonary artery 
hypertension could be found and expressed as ordinal data 
in table 2.  
 
Table 2: cardiovascular and obstetrical comorbidities of the cohort 
 
Comorbidities Number (%) 
Valvular heart disease 
Vascular disease 
Congenital heart disease 
   Active  
   Post operative 
Cardiomyopathy 
Other 
10 (45.45) 
02 (9.09) 
10 (45.45) 
08 (36.36) 
02 (9.09) 
01 (4.55) 
01 (4.55) 
+/ - Pulmonary arterial hypertension [N=16] 
Mild 
Moderate 
Severe 
 
7 (43.75) 
4 (25.00) 
5 (31.25) 
+/- Reversal shunt (right to left) 2 
Obstetric comorbidity / morbidity
*
 [N=21] 
Oligohydramnios 
Previous LSCS 
Pregnancy induced hypertension 
Cholestatsis of pregnancy 
Cephalo pelvic disproportion 
Post dated pregnancy 
Fetal distress / meconium stained liquor 
Breech presentation 
Non progress of labor  
 
05 (23.81) 
02 (9.52) 
01 (4.76) 
02 (9.52) 
01 (4.76) 
02 (9.52) 
02 (9.52) 
02 (9.52) 
02 (9.52) 
Other medical comorbidity [N=22] 
   Hypertension  
   Hyperthyroidism 
   Hypothyroidism  
5 (22.73) 
3 (13.64) 
1 (4.55) 
1 (4.55) 
(LSCS – lower segment cesarean section, *one patient is having one or more comorbidities)  
 
15 (68.18%) of the surgical procedures were 
performed under subarachnoid blocks (SAB); 4 (18.18%) 
were under general anesthesia (GA), and 3 (13.64%) were 
done under epidural anesthesia. The notable hemodynamic 
changes are noted in table 3. There was no significant 
difference among them (p >0.05) taking GA as standard.  
 
Table 3: Comparison of maternal hemodynamics and gross fetal outcome taking GA as standard 
 
Parameters 
GA 
n (%) 
SAB 
n (%) 
P 
value 
Epidural 
n (%) 
P value 
Fall of BP > 20%  2 (50) 9 (60) 1.00 1 (33.33) 1.00 
Fall of HR > 20%  1 (25) 10 (66.67) 0.262 1 (33.33) 1.00 
Vasopressor used
 
2 (50) 10 (66.67) 0.262 2 (66.67) 1.00 
Raise of HR > 20% 2
*
 (50) ?1 (6.67) 0.097 1 (33.33) 1.00 
APGAR <7 in 1 minute None None -- None --- 
(BP – blood pressure, HR – heart rate, GA – general anesthesia, SAB – subarachnoid block, EA- epidural anesthesia, n – number, *at 
the time of laryngoscopy, #one patient required one or more doses) 
 
Most of the patient needed post operative high 
dependant unit care, one patient developed mild 
pulmonary edema and no maternal mortality was noted. 
All the babies were born with APGAR > 7 at 1 min, while 
all except one baby cried immediately after birth. One 
baby was shifted to NICU for further observation. Arterial 
blood pressure was monitored in half of the patients while 
central venous pressure line was used in few cases. No 
patient was managed using pulmonary artery catheter or 
continuous cardiac output monitoring. 
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4. Discussion 
There is no doubt that cardiovascular disease as 
comorbidity is a major contributor to perinatal maternal 
mortality. Mortality rate in pregnant women with cardiac 
disease had been reported from 1.73 – 15% depending on 
the presenting functional NYHA class. [5-7] 
Cardiovascular disease and cardiomyopathy contributes to 
nearly 25% of maternal mortality in United States. [8] 
However, this mortality includes both for vaginal delivery 
as well as cesarean sections. Data with regard to only 
cesarean sections are relatively less in literature. A recent 
study which reviewed the management of pregnant 
patients with pulmonary hypertension managed in a 
tertiary care hospital had found no mortality among 19 
pregnancies. 11 out of these patients were delivered by 
LSCS and six patients had severe pulmonary hypertension. 
[9]  
One of the major apprehension and aim of 
perioperative management of such patient is monitoring 
and maintaining hemodynamics. The Task Force from 
European Society of Cardiology for the management of 
cardiovascular disease in pregnancy recommends that 
maternal risk assessment should be carried out according 
to the modified World Health Organization (WHO) risk 
classification and the high risk group (i.e. women in WHO 
class III and IV needs intensive specialist, cardiac and 
obstetric monitoring throughout the pregnancy, labor and 
puerperium. [10, 11] The need for cardiac / hemodynamic 
monitoring in obstetric patient may be both because of 
obstetric and non obstetric cause in critical care as well as 
in perioperative setting and cardiovascular coexisting 
disease is a potential indication for hemodynamic 
monitoring of such patients. [10-13] However, these 
monitoring are costly, needs good infrastructure and rarely 
available in health care set ups of developing countries; 
where most of the deliveries take place and rheumatic 
heart disease is widely prevalent.  
In the present cohort, elective patients were 
evaluated with transthoracic echocardiography and most of 
the patients were managed with invasive blood pressure 
monitoring along with standard ASA monitoring without 
any mortality. Study conducted by Monagle et al., also 
found similar results in 11 LSCS in patients with 
pulmonary artery hypertension.[9] There is no doubt that 
these patients needs intensive monitoring and management 
in perioperative or peripartum period; yet, successful 
conduction of all the cases including 2 cases with shunt 
reversal and one case of cardiomyopathy with poor left 
ventricular function without continuous cardiac output or 
pulmonary artery catheterization (PAC) also indicates that 
absence of such facility and expertise should not be the 
only reason to refer such cases to a higher centre and 
probably most of such cases can be done in centre with an 
arterial and/or central venous pressure monitoring line and 
ICU backup in the same hospital or nearby. While there 
are reports of using PACs, [9] it is probably not a must. A 
PubMed and Google Scholar search based review of 
literature on hemodynamic monitoring in perioperative 
and critical care management of obstetric patients also 
concluded that noninvasive or minimally invasive 
hemodynamic monitoring appears to be equally effective 
to invasive techniques. [12] Transthoracic 
echocardiography (TOE) allows for a comprehensive 
evaluation of cardiac structure and function when 
compared to pulmonary artery catheterization. [14] 
However, TOE was also not used in any of the patients in 
present cohort. 
GA is believed to provide a stable hemodynamic 
course, if the cardiovascular effects associated with 
laryngoscopy, intubation and oral suction are minimized. 
However, obtunding / minimizing the hemodynamic effect 
of laryngoscopy / intubation by either reducing time of 
laryngoscopy or giving drugs like opioids are not so 
straight forward in pregnant patients as difficult airway 
and in-utero fetus is always a concern here. EA are also an 
attractive options but not feasible in real emergency 
situation if it had not been placed beforehand for labor 
analgesia. SAB has also established itself as a safe 
anesthetic procedure even in patients having moderate to 
severe pulmonary hypertension. [9] In the present cohort, 
there was no mortality in any of GA, EA or SAB group. 
One case of mild pulmonary edema was noted in one 
patient; who recovered well with oxygen, diuretics and 
other supportive measures.  
Oxytocin use is usually not encouraged and it is 
said that haemodynamic changes associated with delivery 
per se may be minor compared with those due to oxytocin 
bolus and bolus should be avoided. [15, 16] If it is used, 
continuous infusion is preferred. [17, 18] Ergometrine 
should also be avoided in severe cardiac disease, as it 
leads to vasoconstriction and hypertension and increases 
the risks of MI and pulmonary edema. In the present study 
cohort, oxytocin was used after delivery in all patients as a 
continuous infusion added in intravenous fluid. 
Hypotension and fall of heart rate was found to be highest 
in SAB; while, rise in heart rate was noted in GA patients 
during laryngoscopy probably due to laryngoscopy reflex. 
However, these changes were not statistically different. 
Phenylephrine 100 mcg as bolus was used to treat 
hypotension mostly, but Mephentermine 6 mg bolus was 
also used. Hemodynamic data were not from electronic 
database; rather from manual entry and graphic 
representations. So, exactness and entry bias is also 
possible. However, data comparison do suggests that SAB 
can be used in such patients safely. 
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The present study and conclusion is however 
weakened by the retrospective nature of the study with low 
samples. Even one next patient or foetus having unwanted 
outcome will give a mortality figure which can be 
regarded as high.  
 
5. Conclusion 
Most of the pregnant women with cardiovascular 
co-morbidity can be managed with minimally invasive or 
non-invasive hemodynamic monitoring and probably can 
be taken up in secondary care set ups. However, nearby 
facility or connection to a centre with postoperative 
multidisciplinary management in a HDU/ICU should be 
there in plan beforehand. Neuraxial anesthesia can be 
safely used in such cases. 
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